ELAD® Concept
ELAD is an extracorporeal bio-artificial liver therapy designed with the intent to allow the patient’s own liver to regenerate to a healthy state, or to stabilize the patient until transplant. ELAD is an allogeneic cellular therapy system based on our human liver-derived cells combined with a reusable bedside unit. Data from ELAD clinical studies has shown trends that may indicate a potential to increase survival rates in patients with acute liver failure. ELAD has received orphan designation in the United States and Europe for the treatment of acute liver failure.
Address: floor 1, block B (21b), neijuxuan workshop, comprehensive bonded zone, No. 33688, jingshidong Road, Jinan area, China (Shandong) pilot Free Trade Zone Telephone:
Copyright: Shandong yiruite Biotechnology Co., Ltd Record No:鲁ICP备20021086 Sign in